This randomized clinical trial aims to evaluate the clinical and radiographic success of NeoPutty MTA compared to formocresol in vital pulpotomy of mandibular primary molars in children aged 4 to 9 years. Participants will be randomly allocated into two groups (1:1) to receive pulpotomy using either NeoPutty MTA or formocresol, followed by restoration with stainless steel crowns. Clinical and radiographic outcomes will be assessed during follow-up visits.
Patient and parent showing cooperation and compliance.
Children 4-9 years old.
Vital carious primary(s) with complete root formation.
Asymptomatic teeth or without clinical symptoms of spontaneous pain.
History of any systemic disease.
Hemostasis is not achieved within 5 minutes of pulp amputation, by direct contact with a wet cotton pellet before the material placement.
The remaining radicular tissue was non-vital (with suppuration or purulence necrosis).